'Nano-drug' hits brain-tumor target: Unique triggering device delivers antitumor drugs

Employing new drug-engineering technology that is part of an advanced science called nanomedicine, a research team has created a "nanobioconjugate" drug that may be given by intravenous injection and carried in the blood to target the brain tumor. It is engineered to specifically permeate the tumor cell wall, entering endosomes, mobile compartments within cells.

Read the whole article on Science Daily

More from Science Daily